Probo Medical Acquires Mi Healthcare


Mi Healthcare has been acquired by Probo Medical, a well-known international supplier of medical imaging equipment, spares, maintenance, and service. The deal’s financial details weren’t made public.

Mi Healthcare is a 1995-founded company situated in Liverpool, UK that offers medical imaging products and services to both public and commercial healthcare facilities all across the country. With offices in both England and Scotland, Mi Healthcare’s staff offers sales, leasing, and service options for ultrasound and x-ray equipment throughout the UK. Currently, Mark Edwards and Tim Dickinson are in charge of Mi Healthcare.

Probo will broaden the scope of its sales, rentals, and service capabilities for diagnostic imaging equipment throughout the UK by acquiring Mi Healthcare. Mi Healthcare is in a strong position to be a key partner for Probo’s ongoing European expansion because to its 25-year track record of excellence in the diagnostic imaging industry.

“Our partnership with Probo will provide a deeper and more comprehensive solution set for our customers, as well as opportunities to best support our growing team.”

Tim Dickinson, Founder of Mi Healthcare.


“We have long known the Probo team, and we are excited for the future of bringing Mi Healthcare into the Probo family. The combination with Probo connects us to a significant platform that allows both organizations to grow faster together, and brings a set of resources to our customers and employees that is unmatched in our sector.”

Mark Edwards, Mi Healthcare’s CEO


“Mi Healthcare is well-known in the UK market as a high-quality service provider for their customers with longstanding relationships that evidence that commitment to quality”, “As we look to harness the shared expertise and collaboration between our teams, we are excited at what this combination will bring to both Probo and Mi Healthcare’s customers.”

Michael Asmer, CEO of Probo

Probo Medical is backed by Avista Capital Partners, a leading New York-based private equity firm with more than 40 growth-oriented healthcare businesses globally.

Next Post

2nd Edition of International Vaccines Congress

We are delighted to announce the online version of “2nd Edition of International Vaccines Congress” (IVC 2022) which is going to be held Virtually during October 19-20, 2022. The global summit strives to provide a meaningful theme of “Synergy to Rehabilitate Innovations in Vaccine Research and Development” and will assemble […]